| Autor: |
Anota, A., Basset, M., Belot, A., Bascoul‐Mollevi, C., Cottone, F., Efficace, F., Préau, M., Touraine, C., Damaj, G., Guidez, S., Labouré, G., Lionne‐Huyghe, P., Bonnet, A., Leyronnas, C., Guieze, R., Launay, V., Drenou, B., Fitoussi, O., Detourmignies, L., Soussain, C. |
| Předmět: |
|
| Zdroj: |
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p428-429, 2p |
| Abstrakt: |
This study aims to provide QoL level for DLBCL patients at diagnosis and after 1 year, and to assess the occurrence of a RS effect. B Introduction: b Few quality of life (QoL) data are available for diffuse large B-cell lymphoma (DLBCL) patients during the first year of diagnosis. Quality of life and response shift effect of diffuse large B-cell lymphoma French patients included in prospective real-life REALYSA cohort in the first year after diagnosis. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text